Nephroprotective Effect of EDL Peptide at Acute Injury of Kidneys of Different Genesis
Zamorskii II, Shchudrova TS, Lin'kova NS, Nichik TE, Khavinson VK · 2017 · Bulletin of experimental biology and medicine. 2017;163:389-393.
Study findings
Synthetic EDL reduced several measures of renal injury, including proteinuria and azotemia, and affected oxidative-stress and energy-related measures.
- Population and setting
- Rats with gentamicin-associated or ischemia/reperfusion kidney injury
- Evidence type
- Animal / experimental
- Preparation
- Synthetic EDL; contextual sequence evidence only
- Source language
- English abstract; original language varies
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- This is EDL sequence research, not a test of marketed Ovagen or Nephropept.
- No evidence here establishes EDL as a constituent isolated from Nephropept or demonstrates human CKD benefit.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
PubMed-indexed abstract and bibliographic metadata checked via Europe PMC; full methods not appraised.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Citation and original source
Original source: Zamorskii II, Shchudrova TS, Lin'kova NS, Nichik TE, Khavinson VK. Nephroprotective Effect of EDL Peptide at Acute Injury of Kidneys of Different Genesis Bulletin of experimental biology and medicine. 2017;163:389-393. 2017.
Molekul research summary: https://molekul.io/research/lineage-28744634. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry